Back to Search
PHYLLIS SENTER, MD
Family Medicine Physician
NPI: 1780646505Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
G34906(CA)
Research & Publications (20)
Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.
PMID 11773615·Proc Natl Acad Sci U S A·2002
7-preclinical
Design, synthesis, and biological evaluation of antibody-drug conjugates comprised of potent camptothecin analogues.
PMID 19469529·Bioconjug Chem·2009
7-preclinical
Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker system.
PMID 19386499·Bioorg Med Chem Lett·2009
7-preclinical
The pharmacologic basis for antibody-auristatin conjugate activity.
PMID 19498104·J Pharmacol Exp Ther·2009
7-preclinical
A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.
PMID 19010911·Cancer Res·2008
7-preclinical
Novel peptide linkers for highly potent antibody-auristatin conjugate.
PMID 18803412·Bioconjug Chem·2008
8-other
Contribution of linker stability to the activities of anticancer immunoconjugates.
PMID 18314937·Bioconjug Chem·2008
7-preclinical
Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB.
PMID 17541593·Cancer Chemother Pharmacol·2007
7-preclinical
Chemotherapy delivery issues in central nervous system malignancy: a reality check.
PMID 17538176·J Clin Oncol·2007
6-review
Minor groove binder antibody conjugates employing a water soluble beta-glucuronide linker.
PMID 17293111·Bioorg Med Chem Lett·2007
8-other
Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen.
PMID 16638870·Clin Cancer Res·2006
7-preclinical
CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.
PMID 16489096·Clin Cancer Res·2006
7-preclinical
Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates.
PMID 16489038·Cancer Res·2006
7-preclinical
Lysosomal trafficking and cysteine protease metabolism confer target-specific cytotoxicity by peptide-linked anti-CD30-auristatin conjugates.
PMID 16484228·J Biol Chem·2006
8-other
Dipeptide-based highly potent doxorubicin antibody conjugates.
PMID 16275070·Bioorg Med Chem Lett·2006
8-other
Design, synthesis, and in vitro evaluation of dipeptide-based antibody minor groove binder conjugates.
PMID 15743178·J Med Chem·2005
7-preclinical
Determining maximal tolerable dose of the monoclonal antibody BR96 labeled with 90Y or 177Lu in rats: establishment of a syngeneic tumor model to evaluate means to improve radioimmunotherapy.
PMID 16203809·Clin Cancer Res·2005
7-preclinical
Arming antibodies: prospects and challenges for immunoconjugates.
PMID 16151407·Nat Biotechnol·2005
6-review
In vivo drug-linker stability of an anti-CD30 dipeptide-linked auristatin immunoconjugate.
PMID 15701875·Clin Cancer Res·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3883 AIRWAY DR
SANTA ROSA, CA 95403 - Phone
- (707) 571-7777
Quick Facts
- NPI
- 1780646505
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile